Reflection and ReactionMortality benefits of influenza vaccination in elderly people
References (3)
- et al.
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy
Lancet Infect Dis
(2007)
There are more references available in the full text version of this article.
Cited by (5)
Postviral Complications: Bacterial Pneumonia
2017, Clinics in Chest MedicineCitation Excerpt :Although influenza vaccination is universally recommended, vaccination against invasive pneumococcal infection is reserved for high-risk groups, including children, the elderly, and patients with immunosuppressive or chronic lung conditions.124,125 Although robust evidence from randomized placebo-controlled trials is lacking, data from animal models of influenza-bacterial coinfection and observational studies in patients have indicated that influenza vaccine can reduce the morbidity and mortality associated with bacterial pneumonia.126–134 Thus, on balance, vaccination against influenza currently represents the most effective public health strategy for reducing the incidence of secondary bacterial pneumonia.
The causes and consequences of seasonal variation in COPD exacerbations
2014, International Journal of COPDEfficacy and effectiveness of influenza vaccination
2011, GeneesmiddelenbulletinInfluenza vaccination now from 60 years of age onwards
2008, Nederlands Tijdschrift voor Geneeskunde2008-2009 Influenza update: A better vaccine match
2008, Cleveland Clinic Journal of Medicine
Copyright © 2008 Elsevier Ltd. All rights reserved.